A single-arm, open-label, phase 2 study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer (NSCLC)

被引：2
|
作者：
Socinski, M. [1 ]
Gil, M. [2 ]
Shahidi, J. [3 ]
Chao, G. Y. [4 ]
Villaruz, L. [1 ]
机构：
[1] Univ Pittsburgh, Med Oncol, UPMC Canc Pavil, Pittsburgh, PA USA
[2] Eli Lilly Polska, Oncol, Warsaw, Poland
[3] Eli Lilly & Co, Oncol, Indianapolis, IN 46285 USA
[4] Eli Lilly & Co, Biostat, Indianapolis, IN 46285 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw383.98
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1298TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer
    Villaruz, Liza C.
    Cobo, Manuel
    Syrigos, Konstantinos
    Mavroudis, Dimitrios
    Zhang, Wei
    Kim, Jong Seok
    Socinski, Mark A.
    LUNG CANCER, 2019, 136 : 52 - 56
  • [2] Nab-paclitaxel maintenance therapy following carboplatin plus nab-paclitaxel combination therapy in chemotherapy naive patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial
    Nakao, Akira
    Uchino, Junji
    Igata, Fumiyasu
    On, Rintaro
    Ikeda, Takato
    Yatsugi, Hiroshi
    Hirano, Ryosuke
    Sasaki, Tomoya
    Tanimura, Keiko
    Imabayashi, Tatsuya
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Nagata, Nobuhiko
    Watanabe, Kentaro
    Kishimoto, Junji
    Takayama, Koichi
    Fujita, Masaki
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 903 - 910
  • [3] An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer
    Spigel, David R.
    Luft, Alexander
    Depenbrock, Henrik
    Ramlau, Rodryg
    Khalil, Mazen
    Kim, Joo-Hang
    Mayo, Carlos
    Chao, Grace Yi
    Obasaju, Coleman
    Natale, Ronald
    CLINICAL LUNG CANCER, 2017, 18 (05) : 480 - 488
  • [4] An open-label, phase II trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel), carboplatin, and bevacizumab in first-line patients with advanced non-squamous non-small cell lung cancer (NSCLC)
    Reynolds, C.
    Barrera, D.
    Vu, D. Q.
    Jotte, R.
    Spira, A. I.
    Weissman, C. H.
    Boehm, K. A.
    Ilegbodu, D.
    Pritchard, S.
    Asmar, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial
    Akira Nakao
    Junji Uchino
    Fumiyasu Igata
    Rintaro On
    Takato Ikeda
    Hiroshi Yatsugi
    Ryosuke Hirano
    Tomoya Sasaki
    Keiko Tanimura
    Tatsuya Imabayashi
    Nobuyo Tamiya
    Yoshiko Kaneko
    Tadaaki Yamada
    Nobuhiko Nagata
    Kentaro Watanabe
    Junji Kishimoto
    Koichi Takayama
    Masaki Fujita
    Investigational New Drugs, 2018, 36 : 903 - 910
  • [6] First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN study
    Dechow, Tobias
    Riera-Knorrenschild, Jorge
    Hackanson, Bjoern
    Janssen, Jan
    Schulz, Holger
    Chiabudini, Marco
    Fischer von Weikersthal, Ludwig
    Budweiser, Stephan
    Nacke, Axel
    Taeuscher, Dagmar
    Welslau, Manfred
    Potthoff, Karin
    CANCER MEDICINE, 2021, 10 (22): : 8127 - 8137
  • [7] NAB-PACLITAXEL IN COMBINATION WITH CARBOPLATIN AS FIRST-LINE THERAPY IN DIABETIC PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Hirsh, Vera
    Owen, Scott
    Ko, Amy
    Renschler, Markus F.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S584 - S584
  • [8] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Hisashi Tanaka
    Kageaki Taima
    Takeshi Morimoto
    Yoshihito Tanaka
    Masamichi Itoga
    Kunihiko Nakamura
    Akihito Hayashi
    Mika Kumagai
    Hideo Yasugahira
    Megumi Mikuniya
    Koichi Okudera
    Shingo Takanashi
    Sadatomo Tasaka
    BMC Cancer, 17
  • [9] A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease
    Usui, Y.
    Kenmotsu, H.
    Mori, K.
    Ono, A.
    Yoh, K.
    Baba, T.
    Fujiwara, Y.
    Yamaguchi, O.
    Ko, R.
    Okamoto, H.
    Yamamoto, N.
    Ninomiya, T.
    Ogura, T.
    Kato, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Single-Arm Phase II Study of Nab-Paclitaxel for Patients with Chemorefractory Non-Small Cell Lung Cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S922 - S922
12345